Emiel J. Th. Rutgers combines Oncology and Internal medicine in his studies. His Internal medicine study frequently links to related topics such as Adjuvant. His Adjuvant study typically links adjacent topics like Oncology. He performs integrative study on Breast cancer and Osteoporosis. He carries out multidisciplinary research, doing studies in Osteoporosis and Bone metastasis. In his research, he undertakes multidisciplinary study on Bone metastasis and Cancer. Emiel J. Th. Rutgers integrates several fields in his works, including Cancer and Breast cancer. His research on Family medicine frequently connects to adjacent areas such as Clinical Practice. His research combines Family medicine and Clinical Practice.
His work in Quality of life (healthcare) covers topics such as Nursing which are related to areas like Patient satisfaction. The study of Breast-conserving surgery, Axillary Dissection and Prophylactic Mastectomy are components of his Mastectomy research. He merges Breast cancer with Carcinoma in his study. In his research, he performs multidisciplinary study on Carcinoma and Ductal carcinoma. He performs integrative study on Ductal carcinoma and Lobular carcinoma in his works. As part of his studies on Cancer, Emiel J. Th. Rutgers often connects relevant subjects like Prophylactic Mastectomy. Internal medicine connects with themes related to Lobular carcinoma in his study. Oncology and Adjuvant are frequently intertwined in his study. His study brings together the fields of Oncology and Adjuvant.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai.
The New England Journal of Medicine (2002)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch;E P Winer;A S Coates;R D Gelber.
Annals of Oncology (2013)
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
Mieke Kriege;Cecile T.M. Brekelmans;Carla Boetes;Peter E. Besnard.
The New England Journal of Medicine (2004)
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
Mila Donker;Geertjan van Tienhoven;Marieke E Straver;Philip Meijnen.
Lancet Oncology (2014)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Fatima Cardoso;Laura J. van’t Veer;Jan Bogaerts;Leen Slaets.
The New England Journal of Medicine (2016)
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
Marc Buyse;Sherene Loi;Laura van't Veer;Giuseppe Viale.
Journal of the National Cancer Institute (2006)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant.
Annals of Oncology (2017)
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
J. Bergh;K. Pritchard;K. Albain;S. Anderson.
The Lancet (2015)
Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial
Saskia Litière;Gustavo Werutsky;Ian S Fentiman;Emiel Rutgers.
Lancet Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: